galectin therapeutics inc
(GALT:Consolidated Issue listed on NASDAQ Capital Market)
Peter G. Traber M.D.
Chief Executive Officer, President, Chief Medical Officer and Director, Galectin Therapeutics, Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 2 different organizations across 2 different industries.|
As of Fiscal Year 2013
Dr. Peter G. Traber, M.D., has been the Chief Executive Officer and President of Galectin Therapeutics, Inc. (alternate name, Pro-Pharmaceuticals Inc.) since March 17, 2011 and serves as its Chief Medical Officer. Dr. Traber serves as the President Emeritus of Baylor College of Medicine. Dr. Traber served as an Acting Chief Medical Officer of Galectin Therapeutics, Inc. since June 15, 2010. Dr. Traber served as the President and Chief Executive Officer, Professor of ...
4960 Peachtree Industrial BoulevardPhone: 678-620-3186
Norcross, Georgia 30071
Board Members Memberships*
Chief Executive Officer, President, Chief Medical Officer and Director
University of Michigan
Wayne State University School of Medicine Detroit
Other Affiliations*There is no Company Affiliations data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|